121 related articles for article (PubMed ID: 19709758)
1. LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R).
Maggi L; Trettel F; Scianni M; Bertollini C; Eusebi F; Fredholm BB; Limatola C
J Neuroimmunol; 2009 Oct; 215(1-2):36-42. PubMed ID: 19709758
[TBL] [Abstract][Full Text] [Related]
2. CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes.
Piccinin S; Di Angelantonio S; Piccioni A; Volpini R; Cristalli G; Fredholm BB; Limatola C; Eusebi F; Ragozzino D
J Neuroimmunol; 2010 Jul; 224(1-2):85-92. PubMed ID: 20570369
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine reduces long-term potentiation in mouse hippocampus.
Takamatsu I; Iwase A; Ozaki M; Kazama T; Wada K; Sekiguchi M
Anesthesiology; 2008 Jan; 108(1):94-102. PubMed ID: 18156887
[TBL] [Abstract][Full Text] [Related]
4. Nicotine gates long-term potentiation in the hippocampal CA1 region via the activation of alpha2* nicotinic ACh receptors.
Nakauchi S; Brennan RJ; Boulter J; Sumikawa K
Eur J Neurosci; 2007 May; 25(9):2666-81. PubMed ID: 17466021
[TBL] [Abstract][Full Text] [Related]
5. Activity of adenosine receptors type 1 Is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons.
Lauro C; Di Angelantonio S; Cipriani R; Sobrero F; Antonilli L; Brusadin V; Ragozzino D; Limatola C
J Immunol; 2008 Jun; 180(11):7590-6. PubMed ID: 18490761
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices.
Bertollini C; Ragozzino D; Gross C; Limatola C; Eusebi F
Neuropharmacology; 2006 Sep; 51(4):816-21. PubMed ID: 16815480
[TBL] [Abstract][Full Text] [Related]
7. Impaired hippocampal LTP in inbred mouse strains can be rescued by beta-adrenergic receptor activation.
Schimanski LA; Ali DW; Baker GB; Nguyen PV
Eur J Neurosci; 2007 Mar; 25(5):1589-98. PubMed ID: 17425584
[TBL] [Abstract][Full Text] [Related]
8. Increased macrophage infiltration and fractalkine expression in cisplatin-induced acute renal failure in mice.
Lu LH; Oh DJ; Dursun B; He Z; Hoke TS; Faubel S; Edelstein CL
J Pharmacol Exp Ther; 2008 Jan; 324(1):111-7. PubMed ID: 17932247
[TBL] [Abstract][Full Text] [Related]
9. High-frequency magnetic stimulation induces long-term potentiation in rat hippocampal slices.
Tokay T; Holl N; Kirschstein T; Zschorlich V; Köhling R
Neurosci Lett; 2009 Sep; 461(2):150-4. PubMed ID: 19539714
[TBL] [Abstract][Full Text] [Related]
10. Theta pulse stimulation: a natural stimulus pattern can trigger long-term depression but fails to reverse long-term potentiation in morphine withdrawn hippocampus area CA1.
Hosseinmardi N; Fathollahi Y; Naghdi N; Javan M
Brain Res; 2009 Nov; 1296():1-14. PubMed ID: 19686713
[TBL] [Abstract][Full Text] [Related]
11. Generation and analysis of mice lacking the chemokine fractalkine.
Cook DN; Chen SC; Sullivan LM; Manfra DJ; Wiekowski MT; Prosser DM; Vassileva G; Lira SA
Mol Cell Biol; 2001 May; 21(9):3159-65. PubMed ID: 11287620
[TBL] [Abstract][Full Text] [Related]
12. Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor.
Wang Q; Wu J; Rowan MJ; Anwyl R
Eur J Neurosci; 2005 Dec; 22(11):2827-32. PubMed ID: 16324117
[TBL] [Abstract][Full Text] [Related]
13. Decreased behavioral activation following caffeine, amphetamine and darkness in A3 adenosine receptor knock-out mice.
Björklund O; Halldner-Henriksson L; Yang J; Eriksson TM; Jacobson MA; Daré E; Fredholm BB
Physiol Behav; 2008 Dec; 95(5):668-76. PubMed ID: 18930070
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and characterization of canine fractalkine and its receptor CX3CR1.
Maeda S; Ohno K; Nakashima K; Fukushima K; Tsukamoto A; Suzuki H; Fujiwara A; Goto-Koshino Y; Fujino Y; Tsujimoto H
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):100-9. PubMed ID: 22169328
[TBL] [Abstract][Full Text] [Related]
15. Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium.
Rius C; Company C; Piqueras L; Cerdá-Nicolás JM; González C; Servera E; Ludwig A; Morcillo EJ; Sanz MJ
Thorax; 2013 Feb; 68(2):177-86. PubMed ID: 23143793
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices.
Zhang W; Miao J; Hao J; Li Z; Xu J; Liu R; Cao F; Wang R; Chen J; Li Z
Peptides; 2009 Jun; 30(6):1197-202. PubMed ID: 19463756
[TBL] [Abstract][Full Text] [Related]
17. Stimulus pattern dependence of the Alzheimer's disease amyloid-beta 42 peptide's inhibition of long term potentiation in mouse hippocampal slices.
Smith JP; Lal V; Bowser D; Cappai R; Masters CL; Ciccotosto GD
Brain Res; 2009 May; 1269():176-84. PubMed ID: 19302985
[TBL] [Abstract][Full Text] [Related]
18. [Neuregulin-1 temperature-dependently inhibits the long-term potentiation in the CA1 region in mouse hippocampal slices].
Chen YJ; Zhang M; Wang P; Zhu XH; Gao TM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1771-4. PubMed ID: 18971168
[TBL] [Abstract][Full Text] [Related]
19. The facilitating effect of systemic administration of Kv7/M channel blocker XE991 on LTP induction in the hippocampal CA1 area independent of muscarinic activation.
Song MK; Cui YY; Zhang WW; Zhu L; Lu Y; Chen HZ
Neurosci Lett; 2009 Sep; 461(1):25-9. PubMed ID: 19463897
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal long-term potentiation is enhanced in urethane-anesthetized RGS2 knockout mice.
Hutchison RM; Chidiac P; Leung LS
Hippocampus; 2009 Aug; 19(8):687-91. PubMed ID: 19294649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
